BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 17714422)

  • 41. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
    Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
    Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
    Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
    Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods.
    Luten M; Roerdinkholder-Stoelwinder B; Schaap NP; de Grip WJ; Bos HJ; Bosman GJ
    Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-D alloimmunization after transfusion of D+ red blood cells.
    Cid J; Ramiro L
    Transfusion; 2009 Jan; 49(1):186-7; author reply 187. PubMed ID: 19140813
    [No Abstract]   [Full Text] [Related]  

  • 46. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-f in a 24-year-old male: a case study.
    Jator EK; Pedde E
    Clin Lab Sci; 2010; 23(2):68-71. PubMed ID: 20499529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age of transfused red cells and early outcomes after cardiac surgery.
    Yap CH; Lau L; Krishnaswamy M; Gaskell M; Yii M
    Ann Thorac Surg; 2008 Aug; 86(2):554-9. PubMed ID: 18640333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.
    Peyrard T; Bardiaux L; Krause C; Kobari L; Lapillonne H; Andreu G; Douay L
    Transfus Med Rev; 2011 Jul; 25(3):206-16. PubMed ID: 21377319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Rh sensitization in the context of trauma: two case reports.
    Werch JB
    J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Red-blood-cell alloimmunization and number of red-blood-cell transfusions.
    Zalpuri S; Zwaginga JJ; le Cessie S; Elshuis J; Schonewille H; van der Bom JG
    Vox Sang; 2012 Feb; 102(2):144-9. PubMed ID: 21729098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.
    Schonewille H; van de Watering LM; Loomans DS; Brand A
    Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hb content-based transfusion policy successfully reduces the number of RBC units transfused.
    Arslan O; Toprak S; Arat M; Kayalak Y
    Transfusion; 2004 Apr; 44(4):485-8. PubMed ID: 15043562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case report: atypical presentation of anti-Rg(a).
    Kahwash E; Talwalkar SS; Leonard J; Lockwood W
    Ann Clin Lab Sci; 2005; 35(1):100-4. PubMed ID: 15830717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
    Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
    Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected.
    Weinstein R; Simard A; Ferschke J; Vauthrin M; Bailey JA; Greene M
    Transfusion; 2015 Jun; 55(6):1327-30. PubMed ID: 25523100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
    Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
    Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury.
    Raval JS; Madden KM; Neal MD; Moore SA
    Transfusion; 2021 Jul; 61 Suppl 1():S144-S149. PubMed ID: 34269429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.